Stem cell therapy

Phase 1Cell therapy

UUniversity Hospital, Basel, Switzerland

Stem cell therapy is one of 130 biologic programs targeting Cerebral Palsy. It is currently in Phase 1.

Indications

Total Trials

Active Trials

129

Competitors

Pipeline

Status by Indication[3][1]

Indication

Cerebral PalsyActive, not recruiting

ParkinsonismActive, not recruiting

Rotator Cuff TearActive, not recruiting

Dilated CardiomyopathyActive, not recruiting

AutismActive, not recruiting

Cerebral PalsyPhase 1/Phase 2

Active, not recruiting

ParkinsonismPhase 1/Phase 2

Active, not recruiting

Rotator Cuff TearPhase 1

Active, not recruiting

Dilated CardiomyopathyPhase 2/Phase 3

Active, not recruiting

AutismPhase 1/Phase 2

Active, not recruiting

Competition

Competitive Landscape

109 competitors in Autism

#DrugCompanyPhaseTrials

Pitocin

RRetrophin

Phase 3

8 2

Prozac

VVitae Pharmaceuticals Inc., an Allergan affiliate

Phase 3

5 3

Luvox

SSolvay Pharmaceuticals

Phase 3

1 4

Bumex

VValidus Pharmaceuticals

Phase 3

1 5

Latuda

SSunovion Respiratory Development Inc.

Phase 3

1 6

Zoloft

VViatris Specialty LLC

Phase 3

1 7

Reminyl

WWim Janssens

Phase 3

1 8

Paliperidone ER

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 3

1 9

Kuvan

BioMarin Pharmaceutical

Phase 3

1 10

Folinic Acid

Roche

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2029

Phase 1Not yet recruiting

Rotator Cuff Tear

NCT07320378

Clinical

Trials by Indication[1]

Rotator Cuff Tear1 trial

Clinical Study on the Safety and Efficacy of Tendon Stem Progenitor Cells Therapy for Rotator Cuff Tears

Not yet recruiting·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·Phase 1·NCT07320378·107 enrolled

Transplantation1 trial

Autologous ADMSC Transplantation in Patients With POI

Unknown status·MMongolian National University of Medical Sciences·Phase 1·NCT06132542·10 enrolled

Safety and Efficacy1 trial

Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Optic Nerve Disease

Unknown status·—·Phase 1/2·NCT01834079·24 enrolled

Parkinsonism1 trial

Clinical Trial to Evaluate Bone Marrow Stem Cell Therapy for PSP, a Rare Form of Parkinsonism

Unknown status·FFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico·Phase 1/2·NCT01824121·25 enrolled

Cerebral Palsy1 trial

Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy

Unknown status·SStem Cells Arabia·Phase 1/2·NCT03078621·50 enrolled

4 more indications

Chronic Wounds1 trial

Hematopoietic Stem Cell Therapy in Chronic Wounds Using a Pressure Sore Model

Unknown status·UUniversity Hospital, Basel, Switzerland·Phase 1·NCT00535548

Autism1 trial

A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism

Unknown status·—·Phase 1/2·NCT01836562·100 enrolled

Angiogenesis1 trial

Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells for Therapeutic Angiogenesis (FOCUS Br)

Completed·TTexas Heart Institute·Phase 1·NCT00314366·21 enrolled

Dilated Cardiomyopathy1 trial

Repetitive Intramyocardial CD34+ Cell Therapy in Dilated Cardiomyopathy (REMEDIUM)

Completed·UUniversity Medical Centre Ljubljana·Phase 2/3·NCT02248532·66 enrolled

Sources

References

[1]
ClinicalTrials.gov — 9 trial records for Stem cell therapy. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Stem cell therapy compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Stem cell therapy. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Hospital, Basel, Switzerland company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Cell therapy[2]
Highest Phase: Phase 1[1]
Company: UUniversity Hospital, Basel, Switzerland

Stem cell therapy

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2029

Trials by Indication[1]

Rotator Cuff Tear1 trial

Transplantation1 trial

Safety and Efficacy1 trial

Parkinsonism1 trial

Cerebral Palsy1 trial

Chronic Wounds1 trial

Autism1 trial

Angiogenesis1 trial

Dilated Cardiomyopathy1 trial

References

Drug Info

Quick Facts

Related News